HomeSPRO • NASDAQ
add
Spero Therapeutics Inc
Nakaraang pagsara
$1.28
Sakop ng araw
$1.27 - $1.35
Sakop ng taon
$0.99 - $1.89
Market cap
74.05M USD
Average na Volume
120.18K
P/E ratio
4.13
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.20M | 275.44% |
Gastos sa pagpapatakbo | 5.53M | -9.24% |
Net na kita | -17.86M | -49.92% |
Net profit margin | -175.17 | 60.07% |
Kita sa bawat share | -0.33 | -43.48% |
EBITDA | -19.06M | -49.12% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 63.53M | -18.23% |
Kabuuang asset | 149.88M | 51.57% |
Kabuuang sagutin | 69.38M | 57.32% |
Kabuuang equity | 80.50M | — |
Natitirang share | 54.05M | — |
Presyo para makapag-book | 0.86 | — |
Return on assets | -30.01% | — |
Return on capital | -50.98% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -17.86M | -49.92% |
Cash mula sa mga operasyon | -18.74M | -0.97% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | -18.74M | -0.97% |
Malayang cash flow | -6.80M | 60.02% |
Tungkol
Itinatag
2013
Website
Mga Empleyado
46
